|
|
|
Lisa A. Jackson, MD, MPH
Senior Investigator
Research Interests:
Dr. Jackson is an internist and infectious disease epidemiologist with
research interests in evaluations of vaccine safety and effectiveness and
the epidemiology of vaccine preventable diseases.
Contact Dr. Jackson:
Voice Mail: 206-442-5216
E-Mail: jackson.l@ghc.org
Curriculum Vitae (CV)
View Dr.
Jackson's CV. You'll need Adobe Reader to view the CV.
Recent Publications:
France EK, Glanz J, Xu S, Hambridge S, Yamasaki K, Black SB, Marcy M,
Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R
for the Vaccine Safety Datalink Team Risk of immune thrombocytopenic purpura
after measles-mumps-rubella immunization in children Pediatrics.
2008;121 e687-e692.
Jackson LA, Starkovich P, Dunstan M, Yu O, Nelson J, Dunn J, Rees T,
Zavitkovsky A, Maus D, Froeschle J, Decker M. A prospective assessment of
the effect of needle length and injection site on the risk of local
reactions to the 5th DTaP vaccination. Pediatrics. 2008;121
e646-e652.
Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008 Aug 2;372(9636):398-405. Abstract
Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine. 2008 Jul 25. [Epub ahead of print]. Abstract
2007
Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick
DS, Psaty BM, Heckbert SR. Newly detected atrial fibrillation and compliance
with antithrombotic guidelines. Arch Intern Med.
2007;167(3):246-52.
Abstract
Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA. Vaccines and
changes in coagulation parameters in adults on chronic warfarin therapy: a
cohort study. Pharmacoepidemiol Drug Saf. 2007 Feb 8; [Epub ahead
of print].
Abstract
Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC, Starkovich
PT, Dunstan M, Carste B, Shay DK, Baggs J, Carlone GM. Immunogenicity of
varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate
vaccine in seniors previously vaccinated with 23-valent pneumococcal
polysaccharide vaccine. Vaccine. 2007;25(20):4029-37.
Epub 2007 Mar 12.
Abstract
Jackson ML, Weiss NS, Nelson JC, Jackson LA. To rule out confounding,
observational studies of influenza vaccine need to include analyses during
the "preinfluenza period". Arch Intern Med. 2007;167(14):1553-4.
Details
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality
benefits of influenza vaccination in elderly people: an ongoing controversy.
Lancet Infect Dis. 2007;7(10):658-66.
Abstract
Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis
E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart
G, Weintraub ES, Davis RL, DeStefano F. Early thimerosal exposure and
neuropsychological outcomes at 7 to 10 years. N Engl J Med.
2007;357(13):1281-92.
Abstract
2006
Chi RC, Jackson LA, Neuzil KM. Characteristics and outcomes of older adults
with community-acquired pneumococcal bacteremia. J Am Geriatr Soc.
2006;54(1):115-20.
Abstract
France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D,
Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA.
Impact of maternal influenza vaccination during pregnancy on the incidence
of acute respiratory illness visits among infants. Arch Pediatr Adolesc
Med. 2006;160(12):1277-83.
Abstract
Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L,
Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR,
Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F. Safety of
trivalent inactivated influenza vaccine in children 6 to 23 months old.
JAMA. 2006;296(16):1990-7.
Abstract
Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges
CB, Jackson LA. Influenza vaccination and risk of incident myocardial
infarction. Hum Vaccin. 2006;2(4):161-6. Epub 2006 Jul 24.
Abstract
Jackson LA, Dunstan M, Starkovich P, Dunn J, Yu O, Nelson JC, Rees T,
Zavitkovsky A. Prophylaxis with acetaminophen or ibuprofen for prevention of
local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis
vaccination: a randomized, controlled trial. Pediatrics.
2006;117(3):620-5.
Abstract
Jackson LA, Jackson ML, Weiss NS. Bias in studies of influenza vaccine
effectiveness: the authors reply to Hak et al. Int J Epidemiol.
2006;35(3):799-800. Epub 2006 Apr 17.
Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, Belongia
E, Zangwill KM, Mullooly J, Nordin J, Marcy SM, DeStefano F. Compliance with
the recommendations for 2 doses of trivalent inactivated influenza vaccine
in children less than 9 years of age receiving influenza vaccine for the
first time: a Vaccine Safety Datalink study. Pediatrics.
2006;118(5):2032-7.
Abstract
Lindsay L, Jackson LA, Savitz DA, Weber DJ, Koch GG, Kong L, Guess HA.
Community influenza activity and risk of acute influenza-like illness
episodes among healthy unvaccinated pregnant and postpartum women. Am J
Epidemiol. 2006;163(9):838-48. Epub 2006 Mar 22.
Abstract
Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA,
Black S, Shay DK; Vaccine Safety Datalink Adult Working Group. Influenza-
and RSV-associated hospitalizations among adults. Vaccine. 2007 Jan
15;25(5):846-55. Epub 2006 Sep 25.
Abstract
Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J,
Destefano F, Shay D. Immunogenicity and reactogenicity of 1 versus 2 doses
of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old
children. J Infect Dis. 2006;194(8):1032-9. Epub 2006 Sep 11.
Abstract
Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P,
Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA. Hepatitis
B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink
study. Pharmacoepidemiol Drug Saf.
2007;16(7):736-45. Epub 2006 Dec 29.
Abstract
2005
Grayston JT, Kronomal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD,
Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C, ACES
Investigators. Azithromycin for the secondary prevention of coronary events.
N Engl J Med. 2005;352(16):1637-45.
Abstract
Jackson LA. Evaluating diabetes mellitus as a risk factor for
community-acquired infections. Clin Infect Dis. 2005;41(3):289-90.
Details
Jackson LA, Benson P, Neuzil KM, Grandjean M, Marino JL. Burden of
community-onset Escherichia coli bacteremia in seniors. J Infect Dis.
2005;191(9):1523-9. Epub 2005 Mar 22.
Abstract
Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias
in estimates of influenza vaccine effectiveness in seniors. Int J
Epidemiol. 2006;35(2):337-44. Epub 2005 Dec 20.
Abstract
Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, Heckbert
SR, Larson EB, Weiss NS. Functional status is a confounder of the
association of influenza vaccine and risk of all cause mortality in seniors.
Int J Epidemiol. 2006;35(2):345-52. Epub 2005 Dec 20.
Abstract
Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D, Baggs
J, Mullooly J, Black S, Shay DK. Assessment of the safety of a third dose of
pneumococcal polysaccharide vaccination in the Vaccine Safety Datalink
population. Vaccine. 2006;24(2):151-6. Epub 2005 Aug 22.
Abstract
Jackson LA, Neuzil KM, Whitney CG, Starkovich P, Dunstan M, Yu O, Nelson
JC, Feikin DR, Shay DK, Baggs J, Carste B, Nahm MH, Carlone G. Safety of
varying dosages of 7-valent pneumococcal protein conjugate vaccine in
seniors previously vaccinated with 23-valent pneumococcal polysaccharide
vaccine. Vaccine. 2005;23(28):3697-703.
Abstract
Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of
herpes zoster, before and after varicella-vaccination-associated decreases
in the incidence of varicella, 1992-2002. J Infect Dis.
2005;191(12):2002-7. Epub 2005 May 12.
Abstract
Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer:
epidemiologic evidence. Cancer Epidemiol Biomarkers Prev.
2005;14(4):773-8.
Abstract
Top |
|
| In the News |
- Flu vaccine may not protect seniors well; Group Health study in Lancet finds no less risk of pneumonia
with vaccine.
See news release.
- Group Health awarded $23 million for new vaccine
research unit.
See news release.
|
|